Abbott Laboratories (ABT) Receives "Hold" Rating from BTIG Research

Leslie Hanson
May 16, 2018

Insiders have sold 86,214 shares of company stock valued at $5,173,042 in the last ninety days. The Argent Trust Company holds 17,590 shares with $1.00 million value, down from 26,235 last quarter. The stock increased 1.24% or $0.76 during the last trading session, reaching $62.02. About 197,022 shares traded.

GW Henssler & Associates Ltd. trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT) by 1.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. ABT outperformed the S&P 500 by 23.30%. 5,332,321 shares of the company's stock traded hands, compared to its average volume of 6,864,525. The hedge fund held 54,794 shares of the consumer services company at the end of 2017Q4, valued at $2.27 million, down from 64,098 at the end of the previous reported quarter. Investigating the productivity proportions of business stock, the speculator will discover its ROE, ROA, ROI remaining at 1.5 percent, 0.7 percent and 2.2 percent, individually. Swiss Fincl Bank invested in 6.61M shares.

Ampio Pharmaceuticals Inc (AMPE) investors sentiment increased to 2.3 in 2017 Q4. It has outperformed by 18.18% the S&P500. The Earnings Yield Five Year average for Abbott Laboratories (NYSE:ABT) is 0.017435. Therefore 100% are positive. Finally, Stifel Nicolaus raised their price objective on Abbott Laboratories from $63.00 to $71.00 and gave the stock a "buy" rating in a research report on Thursday, January 25th. Santander initiated the shares of PAM in report on Thursday, October 8 with "Buy" rating. (NASDAQ:JD) rating on Friday, January 22. Abbott Laboratories presently has a consensus rating of "Buy" and a consensus price target of $67.06. The market capitalization of the corporation settled $53.48B whereas it's P/B Ratio was 10.38. As per Thursday, December 17, the company rating was upgraded by Morgan Stanley. The firm earned "Buy" rating on Wednesday, August 23 by M Partners. New Jersey-based Lord Abbett And Communication Limited Co has invested 0.79% in Abbott Laboratories (NYSE:ABT). Analyst's mean target price for L Brands, Inc. is $44.83. (NASDAQ:JD) to report earnings on August, 13. During the same quarter a year ago, the firm posted $0.48 earnings per share. Comparatively, ABT posted earnings of $0.68 per share in the same quarter, a year earlier. The ratio is more positive, as 23 investment managers started new and increased holdings, while 10 cut down and sold their equity positions in Ampio Pharmaceuticals Inc. Some stocks rarely if ever have high EPS, while others seem like they are always high. The other Nasdaq.com's article was titled "3 Top Healthcare Stocks to Buy in May" and released on May 15, 2018. In a transaction dated March 09, 2018, the shares were put up for sale at an average price of $62.75, raking in a sum of $518,441. It also reduced Pfizer Inc (NYSE:PFE) stake by 4.05 million shares and now owns 27.93M shares. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Wednesday, January 24 with "Buy" rating. Focused Wealth Mgmt holds 0.03% in Abbott Laboratories (NYSE:ABT) or 1,384 shares. Its sales stood at 0.80% a year on average in the period of last five years. The company reported EPS (ttm) of 1.06. The ratio increased due to Abbott Laboratories positioning: 52 sold and 558 reduced.

It is down 0.00% since May 14, 2017 and is. It has change of 0.04, from 2017Q3's 0.87. The institutional investor owned 5,102,874 shares of the healthcare product maker's stock after purchasing an additional 44,314 shares during the period. 123 funds opened positions while 430 raised stakes. Bb&T Corp invested in 0.47% or 443,642 shares.


ABT has been the subject of a number of recent research reports. Moreover, Virginia Retirement Et Al has 0.13% invested in Abbott Laboratories (NYSE:ABT) for 195,800 shares. 50,508 are held by Cadence Natl Bank Na.

The value of a stock is ultimately determined by the amount of cash flow that the investors have available.

The return on assets ratio of the Company was 0.70% while its return on investment ratio was 2.20%. Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 274,640 shares. Provident Trust Communication holds 0.04% or 15,978 shares in its portfolio. D E Shaw & holds 0.01% or 560,567 shares. Jpmorgan Chase And Com stated it has 15.68 million shares or 0.19% of all its holdings. Picton Mahoney Asset Management accumulated 433,800 shares. Tower Bridge Advsr reported 43,978 shares or 0.27% of all its holdings. America First Advisors Lc, a Nebraska-based fund reported 255,635 shares. Finally, Argus lifted their price objective on shares of Abbott Laboratories from $66.00 to $80.00 and gave the stock a "buy" rating in a research note on Tuesday, January 30th. The shares were sold at an average price of $59.61, for a total transaction of $3,362,063.61. Another trade for 1,430 shares valued at $84,344 was made by MANNING JOSEPH J on Wednesday, February 28. On Wednesday, February 28 $62,056 worth of stock was sold by Bracken Sharon J. Also, insider Jaime Contreras sold 849 shares of Abbott Laboratories stock in a transaction dated Monday, April 23rd.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER